Cell MedX Corp. CMXC

Set alert

Price alert · CMXC

All alert types
0.43 +0.43 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
126.33M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CMXC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-243.27 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -10.3×
FY 2017: -129×FY 2018: -65.6×FY 2019: -79.3×FY 2020: -440×FY 2021: -281×FY 2022: -135×FY 2023: -55.1×FY 2024: -13.2×FY 2025: -13.7×FY 2026: -10.3×
FY 2017 5y median -13.7× FY 2026
P/S 0.0×
FY 2017: 26015×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 5106×FY 2021: 37803×FY 2022: 15531×FY 2023: 9910×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B -4.7×
FY 2017: -138×FY 2018: -94.6×FY 2019: -41.2×FY 2020: -322×FY 2021: -162×FY 2022: -46.9×FY 2023: -11.5×FY 2024: -2.3×FY 2025: -6.5×FY 2026: -4.7×
FY 2017 5y median -6.5× FY 2026
P/FCF -27.3×
FY 2017: -187×FY 2018: -226×FY 2019: -236×FY 2020: -527×FY 2021: -455×FY 2022: -209×FY 2023: -101×FY 2024: -12.8×FY 2025: -57.5×FY 2026: -27.3×
FY 2017 5y median -57.5× FY 2026
EV/EBITDA 0.0×
FY 2017: -151×FY 2018: -73.5×FY 2019: -110×FY 2020: -473×FY 2021: -292×FY 2022: -141×FY 2023: -63.3×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
EV/Sales 0.0×
FY 2017: 26091×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 5111×FY 2021: 37844×FY 2022: 15629×FY 2023: 10237×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -3.7%
FY 2017: -0.5%FY 2018: -0.4%FY 2019: -0.4%FY 2020: -0.2%FY 2021: -0.2%FY 2022: -0.5%FY 2023: -1.0%FY 2024: -7.8%FY 2025: -1.7%FY 2026: -3.7%
FY 2017 5y median -1.7% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 34.9%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 89.3%FY 2021: 52.1%FY 2022: 66.5%FY 2023: 17.5%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: -19251.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -1083.6%FY 2021: -10724.0%FY 2022: -11074.9%FY 2023: -16207.7%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: -20087.6%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -1140.3%FY 2021: -13469.9%FY 2022: -11498.4%FY 2023: -17923.3%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE 49.4%
FY 2017: 106.9%FY 2018: 144.1%FY 2019: 52.1%FY 2020: 71.9%FY 2021: 57.8%FY 2022: 34.7%FY 2023: 20.8%FY 2024: 17.2%FY 2025: 45.4%FY 2026: 49.4%
FY 2017 5y median 34.7% FY 2026
ROIC 0.0%
FY 2017: 190.7%FY 2018: 160.6%FY 2019: 70.5%FY 2020: 102.0%FY 2021: 56.9%FY 2022: 48.2%FY 2023: 32.5%FY 2024: 61.4%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 32.5% FY 2026
ROA -1099.2%
FY 2017: -425.4%FY 2018: -3417.7%FY 2019: -484.3%FY 2020: -686.5%FY 2021: -1743.5%FY 2022: -1686.8%FY 2023: -479.4%FY 2024: -308.9%FY 2025: -2668.4%FY 2026: -1099.2%
FY 2017 5y median -1099.2% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -83.0%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -92.9%FY 2022: -10.3%FY 2023: -54.5%FY 2024: -100.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 0.0%
FY 2017: 43.0%FY 2018: -28.2%FY 2019: 42.1%FY 2020: -16.8%FY 2021: 30.2%FY 2022: 7.4%FY 2023: 33.4%FY 2024: 30.0%FY 2025: 100.0%FY 2026: 0.0%
FY 2017 FY 2026
EPS (diluted) -33.3%
FY 2017: 50.9%FY 2018: -8.0%FY 2019: 43.2%FY 2020: 0.0%FY 2021: 25.5%FY 2022: 28.4%FY 2023: 28.8%FY 2024: 57.0%FY 2025: -782.4%FY 2026: -33.3%
FY 2017 FY 2026
Free Cash Flow -120.4%
FY 2017: -35.0%FY 2018: 48.0%FY 2019: 31.1%FY 2020: -200.0%FY 2021: 39.5%FY 2022: 19.8%FY 2023: 39.6%FY 2024: 46.4%FY 2025: 2.9%FY 2026: -120.4%
FY 2017 FY 2026

Financial Health

Current Ratio 0.0×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Quick Ratio 0.0×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Debt / Equity 0.0×
FY 2017: -0.5×FY 2018: -0.1×FY 2019: -0.3×FY 2020: -0.3×FY 2021: -0.2×FY 2022: -0.3×FY 2023: -0.4×FY 2024: -0.4×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median -0.3× FY 2026
Net Debt / EBITDA 0.0×
FY 2017: -0.4×FY 2018: -0.1×FY 2019: -0.7×FY 2020: -0.4×FY 2021: -0.3×FY 2022: -0.9×FY 2023: -2.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Interest Coverage 0.0×
FY 2017: -23.0×FY 2018: -137×FY 2019: -53.2×FY 2020: -49.3×FY 2021: -22.6×FY 2022: -26.2×FY 2023: -9.4×FY 2024: -5.1×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median -5.1× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-05-31